1. Home
  2. BIVI vs BNKK Comparison

BIVI vs BNKK Comparison

Compare BIVI & BNKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioVie Inc.

BIVI

BioVie Inc.

N/A

Current Price

$1.75

Market Cap

10.3M

Sector

Health Care

ML Signal

N/A

BNKK

Bonk Inc.

N/A

Current Price

$1.34

Market Cap

10.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
BIVI
BNKK
Founded
2013
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.3M
10.6M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
BIVI
BNKK
Price
$1.75
$1.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.9M
142.9K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
74.83
N/A
EPS
N/A
N/A
Revenue
N/A
$2,117,309.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
201.63
52 Week Low
$0.82
$0.11
52 Week High
$3.79
$7.19

Technical Indicators

Market Signals
Indicator
BIVI
BNKK
Relative Strength Index (RSI) 44.57 55.23
Support Level $1.12 $1.25
Resistance Level $1.74 $1.47
Average True Range (ATR) 0.20 0.11
MACD -0.04 0.01
Stochastic Oscillator 10.48 52.73

Price Performance

Historical Comparison
BIVI
BNKK

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About BNKK Bonk Inc.

Bonk Inc provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It sells its products through direct customers, distributors, retailers, and e-commerce websites. The company generates revenue through various channels, its primary sales include nostingz suncare products which are sold through e-commerce platforms, licensing revenues from Photocil and sales of the Safety Shot Beverage. The company has two reportable segments: the dietary and energy beverage business and digital assets, consisting of investing for growth in the appreciation of the asset. It derives the majority of the revenue from the dietary and energy beverage segment.

Share on Social Networks: